Sale!

TTN Gene Cardiomyopathy Dilated Type 1G NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TTN Gene Cardiomyopathy Dilated Type 1G NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the TTN gene associated with dilated cardiomyopathy type 1G. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that can lead to heart muscle weakening and enlargement. Individuals with family history of cardiomyopathy, unexplained heart failure symptoms, or abnormal echocardiogram results should consider this test. Early detection enables proactive management, personalized treatment plans, and informed family planning decisions. The test provides crucial information for cardiologists to develop targeted interventions and monitor at-risk family members. Available for only $500 USD, this test offers peace of mind and potentially life-saving insights into hereditary cardiac conditions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TTN Gene Cardiomyopathy Dilated Type 1G NGS Genetic DNA Test

Comprehensive Introduction to TTN Gene Cardiomyopathy Testing

The TTN Gene Cardiomyopathy Dilated Type 1G NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing method focuses on identifying mutations in the titin (TTN) gene, which plays a crucial role in maintaining the structural integrity and function of heart muscle cells. Dilated cardiomyopathy type 1G is a hereditary condition characterized by the enlargement and weakening of the heart’s main pumping chamber, leading to reduced cardiac output and potential heart failure.

Understanding your genetic predisposition to this condition is vital for early intervention and personalized medical management. The test’s importance extends beyond individual diagnosis, as it provides valuable information for family members who may be at risk, enabling proactive healthcare decisions and potentially preventing serious cardiac complications.

What the Test Measures and Detects

This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire TTN gene, which is one of the largest human genes encoding the titin protein. The test specifically detects:

  • Pathogenic variants and mutations in the TTN gene associated with dilated cardiomyopathy type 1G
  • Single nucleotide polymorphisms (SNPs) that may impact cardiac function
  • Insertions, deletions, and copy number variations affecting the titin protein structure
  • Genetic markers that influence disease progression and treatment response
  • Inheritance patterns that help determine familial risk assessment

Who Should Consider This Test

This genetic test is particularly recommended for individuals experiencing specific symptoms or having certain risk factors:

Symptoms and Clinical Indicators

  • Unexplained shortness of breath during routine activities
  • Persistent fatigue and reduced exercise tolerance
  • Swelling in legs, ankles, or abdomen (edema)
  • Irregular heartbeats or palpitations
  • Family history of sudden cardiac death or heart failure
  • Abnormal echocardiogram results showing enlarged heart chambers
  • Unexplained fainting episodes or dizziness

Risk Factors

  • First-degree relatives diagnosed with dilated cardiomyopathy
  • Family members with known TTN gene mutations
  • Individuals with unexplained left ventricular dysfunction
  • Patients planning pregnancy with family cardiac history
  • Competitive athletes with family history of cardiac conditions

Significant Benefits of Genetic Testing

Undergoing the TTN Gene Cardiomyopathy test provides numerous advantages for both patients and healthcare providers:

  • Early Detection and Intervention: Identify genetic risks before symptoms develop, allowing for proactive management
  • Personalized Treatment Plans: Enable cardiologists to create targeted therapy regimens based on genetic findings
  • Family Risk Assessment: Provide crucial information for relatives who may benefit from screening
  • Reproductive Planning: Assist in family planning decisions for individuals with hereditary cardiac conditions
  • Reduced Diagnostic Uncertainty: Eliminate prolonged diagnostic odysseys and provide definitive answers
  • Improved Monitoring: Establish appropriate surveillance protocols for at-risk individuals
  • Psychological Relief: Reduce anxiety through knowledge and understanding of genetic status

Understanding Your Test Results

Interpreting genetic test results requires professional medical guidance, but here’s a general overview of potential outcomes:

Positive Result

A positive result indicates the presence of a pathogenic TTN gene mutation associated with dilated cardiomyopathy type 1G. This finding necessitates:

  • Comprehensive cardiac evaluation and regular monitoring
  • Implementation of preventive measures and lifestyle modifications
  • Discussion of treatment options with a cardiologist
  • Genetic counseling for family members

Negative Result

A negative result suggests no known disease-causing mutations were detected in the TTN gene. However:

  • This doesn’t completely rule out other genetic or non-genetic causes of cardiomyopathy
  • Continued monitoring may be recommended based on clinical symptoms
  • Other genetic tests might be considered if clinical suspicion remains high

Variant of Uncertain Significance (VUS)

Some results may identify genetic changes with unclear clinical implications. In such cases:

  • Additional family member testing may help clarify significance
  • Regular follow-up as new research emerges is essential
  • Clinical management should be based on current symptoms and family history

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700

Additional Test Information

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Specialty: Cardiologist
  • Department: Genetics
  • Method: NGS Technology
  • Disease Type: Cardiovascular Pneumology Disorders

Pre-Test Instructions

Before undergoing testing, patients should provide:

  • Complete clinical history related to cardiac symptoms
  • Participation in a genetic counseling session
  • Development of a pedigree chart documenting family members affected by TTN gene cardiomyopathy
  • Detailed information about family cardiac history

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, and many other cities. Our network of certified genetic counselors and cardiology specialists ensures you receive comprehensive care regardless of your location.

Take Control of Your Cardiac Health Today

Don’t wait for symptoms to develop before understanding your genetic risk for dilated cardiomyopathy. Early detection through genetic testing can significantly impact your long-term cardiac health and quality of life. Our team of genetic specialists and cardiologists are ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your TTN Gene Cardiomyopathy Dilated Type 1G NGS Genetic DNA Test and take the first step toward proactive cardiac care management.

Our compassionate healthcare professionals understand the emotional aspects of genetic testing and are committed to providing supportive, confidential care throughout your journey. Book your appointment now to gain valuable insights into your cardiac health and make informed decisions for your future wellbeing.